Kenalog-10
Minneapolis, MN
Dr. Maria Hordinsky, at the University of Minnesota is conducting a study examining the relationship between a commonly utilized treatment for alopecia areata, Kenalog-10 intralesional injections in combination with a filler
Otherwise healthy patients diagnosed with alopecia areata with over 50% of scalp involvement will be eligible for enrollment in this study. Those enrolled will undergo intralesional Kenalog-10 (triamcinolone acetonide10mg/mL) and filler injections every 6 weeks for a period 12 weeks. This period will be followed by a 6 injection-free, follow-up visit. This study will advance the understanding of the effects of this highly utilized therapy in combination with a filler.
